Rossmore Private Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $221K | Sell |
2,793
-1,079
| -28% | -$87K | 0.02% | 289 |
|
|
2026
Q1 | $338K | Sell |
3,872
-84
| -2% | -$8.05K | 0.03% | 237 |
|
|
2025
Q4 | $383K | Hold |
3,956
| – | – | 0.03% | 224 |
|
|
2025
Q3 | $377K | Sell |
3,956
-55
| -1% | -$5.06K | 0.04% | 208 |
|
|
2025
Q2 | $350K | Sell |
4,011
-1,083
| -21% | -$91.8K | 0.04% | 209 |
|
|
2025
Q1 | $458K | Sell |
5,094
-3,930
| -44% | -$352K | 0.06% | 181 |
|
|
2024
Q4 | $721K | Sell |
9,024
-3,908
| -30% | -$338K | 0.09% | 150 |
|
|
2024
Q3 | $1.16M | Hold |
12,932
| – | – | 0.14% | 115 |
|
|
2024
Q2 | $1.02M | Sell |
12,932
-699
| -5% | -$57.3K | 0.13% | 119 |
|
|
2024
Q1 | $1.19M | Buy |
13,631
+283
| +2% | +$24.2K | 0.16% | 109 |
|
|
2023
Q4 | $1.1M | Sell |
13,348
-2
| -0% | -$152 | 0.16% | 111 |
|
|
2023
Q3 | $1.05M | Sell |
13,350
-6
| -0% | -$502 | 0.16% | 106 |
|
|
2023
Q2 | $1.18M | Hold |
13,356
| – | – | 0.18% | 103 |
|
|
2023
Q1 | $1.08M | Sell |
13,356
-654
| -5% | -$53.3K | 0.17% | 106 |
|
|
2022
Q4 | $1.05M | Sell |
14,010
-202
| -1% | -$16.4K | 0.17% | 103 |
|
|
2022
Q3 | $1.15M | Sell |
14,212
-382
| -3% | -$34.3K | 0.21% | 88 |
|
|
2022
Q2 | $1.31M | Hold |
14,594
| – | – | 0.23% | 87 |
|
|
2022
Q1 | $1.62M | Sell |
14,594
-100
| -0.7% | -$10.6K | 0.25% | 86 |
|
|
2021
Q4 | $1.52M | Buy |
14,694
+62
| +0.4% | +$7.18K | 0.24% | 86 |
|
|
2021
Q3 | $1.83M | Hold |
14,632
| – | – | 0.31% | 75 |
|
|
2021
Q2 | $1.82M | Buy |
14,632
+96
| +0.7% | +$12.1K | 0.31% | 77 |
|
|
2021
Q1 | $1.72M | Buy |
14,536
+907
| +7% | +$106K | 0.32% | 76 |
|
|
2020
Q4 | $1.6M | Buy |
13,629
+2,485
| +22% | +$274K | 0.32% | 78 |
|
|
2020
Q3 | $1.16M | Buy |
11,144
+1,662
| +18% | +$167K | 0.27% | 88 |
|
|
2020
Q2 | $869K | Buy |
9,482
+1,965
| +26% | +$188K | 0.24% | 89 |
|
|
2020
Q1 | $678K | Buy |
7,517
+2,124
| +39% | +$226K | 0.23% | 92 |
|
|
2019
Q4 | $612K | Buy |
5,393
+1,402
| +35% | +$154K | 0.19% | 80 |
|
|
2019
Q3 | $434K | Hold |
3,991
| – | – | 0.15% | 96 |
|
|
2019
Q2 | $389K | Buy |
3,991
+1,452
| +57% | +$133K | 0.14% | 93 |
|
|
2019
Q1 | $231K | Hold |
2,539
| – | – | 0.09% | 118 |
|
|
2018
Q4 | $231K | Buy |
2,539
+100
| +4% | +$9.35K | 0.1% | 115 |
|
|
2018
Q3 | $240K | Buy |
2,439
+50
| +2% | +$4.62K | 0.1% | 117 |
|
|
2018
Q2 | $205K | Sell |
2,389
-430
| -15% | -$35.9K | 0.13% | 104 |
|
|
2018
Q1 | $226K | Buy |
2,819
+383
| +16% | +$31.6K | 0.23% | 87 |
|
|
2017
Q4 | $197K | Buy |
+2,436
| New | +$195K | 0.2% | 93 |
|
Other funds holding MDT
FWIA
GAM
SRIM
DC
Rossmore Private Capital's MDT Position: Q2 2026 in Review
Rossmore Private Capital reduced its Medtronic (MDT) stake by 28% in Q2 2026, selling an estimated $87K and leaving 2,793 shares worth $221K. The position accounts for 0.02% of the portfolio, ranked #289.
Rossmore Private Capital first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.83M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Rossmore Private Capital held 2,793 shares of Medtronic worth $221K as of Q2 2026.
- Rossmore Private Capital sold 1,079 Medtronic shares in Q2 2026, an estimated $87K.
- Medtronic made up 0.02% of Rossmore Private Capital's portfolio in Q2 2026, its #289 holding.
- Rossmore Private Capital first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
- Rossmore Private Capital's Medtronic position peaked at $1.83M in Q3 2021.
- 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.